Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology.

Mast Reforestation built the only vertically integrated solution to reforest the growing pool of millions of acres that have been damaged by wildfire.

Shift4Good is a venture capital firm backing the startups decarbonizing the transportation industry. SHIFT4GOOD can deploy between €0.5m and and €20m per company. Shift4Good mostly invest in Series A and Series B rounds and can allocate 10% of our funds to pre-Series A rounds.

Fundment is an innovative company that combines discretionary fund management with advanced digital investment technology to enhance adviser services. The firm provides a platform that automates operational aspects of investment, making it easier for financial advisers to manage their clients' portfolios effectively.